$SCPH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in scPharmaceuticals Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in scPharmaceuticals Inc.. Get notifications about new insider transactions in scPharmaceuticals Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17 2021 | SCPH | scPharmaceuticals ... | Abraham William Tober | Director | Option Exercise | A | 7.25 | 32,600 | 236,350 | 32,600 | |
| Jan 27 2021 | SCPH | scPharmaceuticals ... | Tucker John H | President and CEO | Option Exercise | A | 7.06 | 112,050 | 791,073 | 112,050 | |
| Jan 27 2021 | SCPH | scPharmaceuticals ... | Nokes Rachael | See Remarks | Option Exercise | A | 7.06 | 49,200 | 347,352 | 49,200 | |
| Jul 13 2020 | SCPH | scPharmaceuticals ... | Bonstein Sara | Director | Option Exercise | A | 8.23 | 12,248 | 100,801 | 12,248 | |
| Jul 02 2020 | SCPH | scPharmaceuticals ... | Tucker John H | President and CEO | Option Exercise | A | 3.25 | 42,250 | 137,313 | 42,250 | |
| Jul 02 2020 | SCPH | scPharmaceuticals ... | Tucker John H | President and CEO | Option Exercise | M | 0.00 | 42,250 | 0 | 0 | |
| Jul 02 2020 | SCPH | scPharmaceuticals ... | Tucker John H | President and CEO | Payment of Exercise | F | 7.36 | 10,288 | 75,720 | 36,962 | 47.3 K to 37 K (-21.77 %) |
| Jul 02 2020 | SCPH | scPharmaceuticals ... | Tucker John H | President and CEO | Buy | M | 0.00 | 42,250 | 0 | 47,250 | 5 K to 47.3 K (+845.00 %) |
| Jun 11 2020 | SCPH | scPharmaceuticals ... | Coleman Dorothy | Director | Option Exercise | A | 7.96 | 6,124 | 48,747 | 6,124 | |
| Jun 11 2020 | SCPH | scPharmaceuticals ... | Agger Mette Kirstine | Director | Option Exercise | A | 7.96 | 6,124 | 48,747 | 6,124 | |
| Jun 11 2020 | SCPH | scPharmaceuticals ... | Hudson Frederick M. | Director | Option Exercise | A | 7.96 | 6,124 | 48,747 | 6,124 | |
| Jun 11 2020 | SCPH | scPharmaceuticals ... | VEITINGER KLAUS R DR | Director | Option Exercise | A | 7.96 | 6,124 | 48,747 | 6,124 | |
| Jun 11 2020 | SCPH | scPharmaceuticals ... | Baylor-Henry Minnie | Director | Option Exercise | A | 7.96 | 6,124 | 48,747 | 6,124 | |
| Jun 11 2020 | SCPH | scPharmaceuticals ... | Khattar Jack A. | Director | Option Exercise | A | 7.96 | 6,124 | 48,747 | 6,124 | |
| Jun 11 2020 | SCPH | scPharmaceuticals ... | Freeman Mason | Director | Option Exercise | A | 7.96 | 6,124 | 48,747 | 6,124 | |
| Jun 11 2020 | SCPH | scPharmaceuticals ... | SCHAEFFER LEONARD D | Director | Option Exercise | A | 7.96 | 6,124 | 48,747 | 6,124 | |
| May 28 2020 | SCPH | scPharmaceuticals ... | Schwab Andrew J. | 10% Owner | Buy | P | 8.65 | 578,034 | 4,999,994 | 578,034 | 0 to 578 K |
| May 26 2020 | SCPH | scPharmaceuticals ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 8.65 | 231,200 | 1,999,880 | 231,200 | 0 to 231.2 K |
| May 26 2020 | SCPH | scPharmaceuticals ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 8.65 | 1,156,083 | 10,000,118 | 4,565,948 | 3.4 M to 4.6 M (+33.90 %) |
| May 26 2020 | SCPH | scPharmaceuticals ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 8.65 | 231,200 | 1,999,880 | 231,200 | 0 to 231.2 K |
| May 26 2020 | SCPH | scPharmaceuticals ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 8.65 | 1,156,083 | 10,000,118 | 4,565,948 | 3.4 M to 4.6 M (+33.90 %) |
| Jan 14 2020 | SCPH | scPharmaceuticals ... | Tucker John H | President and CEO | Option Exercise | A | 5.81 | 127,500 | 740,775 | 127,500 | |
| Jan 14 2020 | SCPH | scPharmaceuticals ... | Nokes Rachael | See Remarks | Option Exercise | A | 5.81 | 44,500 | 258,545 | 44,500 | |
| Dec 17 2019 | SCPH | scPharmaceuticals ... | Tucker John H | President and CEO | Buy | P | 5.24 | 5,000 | 26,189 | 5,000 | 0 to 5 K |
| Jun 20 2019 | SCPH | scPharmaceuticals ... | SCHAEFFER LEONARD D | Director | Option Exercise | A | 3.37 | 6,124 | 20,638 | 6,124 | |
| Jun 20 2019 | SCPH | scPharmaceuticals ... | Baylor-Henry Minnie | Director | Option Exercise | A | 3.37 | 6,124 | 20,638 | 6,124 | |
| Jun 20 2019 | SCPH | scPharmaceuticals ... | Agger Mette Kirstine | Director | Option Exercise | A | 3.37 | 6,124 | 20,638 | 6,124 | |
| Jun 20 2019 | SCPH | scPharmaceuticals ... | Freeman Mason | Director | Option Exercise | A | 3.37 | 6,124 | 20,638 | 6,124 | |
| Jun 20 2019 | SCPH | scPharmaceuticals ... | Khattar Jack A. | Director | Option Exercise | A | 3.37 | 6,124 | 20,638 | 6,124 | |
| Jun 20 2019 | SCPH | scPharmaceuticals ... | VEITINGER KLAUS R DR | Director | Option Exercise | A | 3.37 | 6,124 | 20,638 | 6,124 | |
| Jun 20 2019 | SCPH | scPharmaceuticals ... | Coleman Dorothy | Director | Option Exercise | A | 3.37 | 6,124 | 20,638 | 6,124 | |
| Jun 20 2019 | SCPH | scPharmaceuticals ... | Hudson Frederick M. | Director | Option Exercise | A | 3.37 | 6,124 | 20,638 | 6,124 | |
| Apr 15 2019 | SCPH | scPharmaceuticals ... | RA CAPITAL MANAGEMENT, LLC | 10% Owner | Buy | P | 2.70 | 389,862 | 1,052,627 | 3,247,005 | 2.9 M to 3.2 M (+13.65 %) |
| Jul 24 2018 | SCPH | scPharmaceuticals ... | Baylor-Henry Minnie | Director | Option Exercise | A | 4.80 | 12,248 | 58,790 | 12,248 | |
| Jul 24 2018 | SCPH | scPharmaceuticals ... | Freeman Mason | Director | Option Exercise | A | 4.80 | 12,248 | 58,790 | 12,248 | |
| Jun 21 2018 | SCPH | scPharmaceuticals ... | Agger Mette Kirstine | Director | Option Exercise | A | 5.53 | 6,124 | 33,866 | 6,124 | |
| Jun 21 2018 | SCPH | scPharmaceuticals ... | VEITINGER KLAUS R DR | Director | Option Exercise | A | 5.53 | 6,124 | 33,866 | 6,124 | |
| Jun 21 2018 | SCPH | scPharmaceuticals ... | PARMAR KUSH | Director | Option Exercise | A | 5.53 | 6,124 | 33,866 | 6,124 | |
| Jun 21 2018 | SCPH | scPharmaceuticals ... | Khattar Jack A. | Director | Option Exercise | A | 5.53 | 6,124 | 33,866 | 6,124 | |
| Jun 21 2018 | SCPH | scPharmaceuticals ... | SCHAEFFER LEONARD D | Director | Option Exercise | A | 5.53 | 6,124 | 33,866 | 6,124 | |
| Jun 21 2018 | SCPH | scPharmaceuticals ... | Coleman Dorothy | Director | Option Exercise | A | 5.53 | 6,124 | 33,866 | 6,124 | |
| Jun 21 2018 | SCPH | scPharmaceuticals ... | Hudson Frederick M. | Director | Option Exercise | A | 5.53 | 12,248 | 67,731 | 12,248 | |
| Jan 19 2018 | SCPH | scPharmaceuticals ... | Ignelzi Troy A. | Chief Financial Off ... | Option Exercise | A | 12.23 | 42,616 | 521,194 | 42,616 | |
| Jan 19 2018 | SCPH | scPharmaceuticals ... | Tucker John H | President and CEO | Option Exercise | A | 12.23 | 100,000 | 1,223,000 | 100,000 | |
| Jan 19 2018 | SCPH | scPharmaceuticals ... | Ceesay Abraham | Chief Operating Off ... | Option Exercise | A | 12.23 | 80,971 | 990,275 | 80,971 | |
| Dec 20 2017 | SCPH | scPharmaceuticals ... | SCHAEFFER LEONARD D | Director | Option Exercise | M | 1.66 | 22,631 | 37,567 | 5,223 | |
| Dec 20 2017 | SCPH | scPharmaceuticals ... | SCHAEFFER LEONARD D | Director | Buy | M | 1.66 | 22,631 | 37,567 | 57,449 | 34.8 K to 57.4 K (+65.00 %) |
| Nov 24 2017 | SCPH | scPharmaceuticals ... | SUN PHARMACEUTICAL INDUSTRIES ... | 10% Owner | Option Exercise | C | 0.00 | 13,000,000 | 0 | 0 | |
| Nov 24 2017 | SCPH | scPharmaceuticals ... | SUN PHARMACEUTICAL INDUSTRIES ... | 10% Owner | Buy | P | 14.00 | 357,143 | 5,000,002 | 357,143 | 0 to 357.1 K |
| Nov 24 2017 | SCPH | scPharmaceuticals ... | SUN PHARMACEUTICAL INDUSTRIES ... | 10% Owner | Buy | C | 0.00 | 1,810,536 | 0 | 1,810,536 | 0 to 1.8 M |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | SCHAEFFER LEONARD D | Director | Option Exercise | C | 0.00 | 309,501 | 0 | 0 | |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | SCHAEFFER LEONARD D | Director | Option Exercise | C | 0.00 | 250,000 | 0 | 0 | |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | SCHAEFFER LEONARD D | Director | Buy | C | 0.00 | 43,104 | 0 | 43,104 | 0 to 43.1 K |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | SCHAEFFER LEONARD D | Director | Buy | C | 0.00 | 34,818 | 0 | 34,818 | 0 to 34.8 K |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | Coleman Dorothy | Director | Option Exercise | C | 0.00 | 103,024 | 0 | 0 | |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | Coleman Dorothy | Director | Buy | C | 0.00 | 14,348 | 0 | 14,348 | 0 to 14.3 K |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | Lundbeckfond Invest A/S | 10% Owner | Option Exercise | C | 0.00 | 7,067,945 | 0 | 0 | |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | Lundbeckfond Invest A/S | 10% Owner | Option Exercise | C | 0.00 | 11,092,383 | 0 | 0 | |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | Lundbeckfond Invest A/S | 10% Owner | Buy | P | 14.00 | 654,762 | 9,166,668 | 3,183,986 | 2.5 M to 3.2 M (+25.89 %) |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | Lundbeckfond Invest A/S | 10% Owner | Buy | C | 0.00 | 984,366 | 0 | 2,529,224 | 1.5 M to 2.5 M (+63.72 %) |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | Lundbeckfond Invest A/S | 10% Owner | Buy | C | 0.00 | 1,544,858 | 0 | 1,544,858 | 0 to 1.5 M |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | Agger Mette Kirstine | Director | Option Exercise | C | 0.00 | 7,067,945 | 0 | 0 | |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | Agger Mette Kirstine | Director | Option Exercise | C | 0.00 | 11,092,383 | 0 | 0 | |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | Agger Mette Kirstine | Director | Buy | C | 0.00 | 984,366 | 0 | 2,529,224 | 1.5 M to 2.5 M (+63.72 %) |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | Agger Mette Kirstine | Director | Buy | C | 0.00 | 1,544,858 | 0 | 1,544,858 | 0 to 1.5 M |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | SILVERSTEIN JONATHAN | Director | Option Exercise | C | 0.00 | 18,500,000 | 0 | 0 | |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | SILVERSTEIN JONATHAN | Director | Buy | C | 0.00 | 2,576,532 | 0 | 2,576,532 | 0 to 2.6 M |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | 5AM Partners IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 302,652 | 0 | 0 | |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | 5AM Partners IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 443,708 | 0 | 0 | |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | 5AM Partners IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 7,263,649 | 0 | 0 | |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | 5AM Partners IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 10,649,003 | 0 | 0 | |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | 5AM Partners IV, LLC | 10% Owner | Buy | P | 14.00 | 26,190 | 366,660 | 130,135 | 103.9 K to 130.1 K (+25.20 %) |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | 5AM Partners IV, LLC | 10% Owner | Buy | C | 0.00 | 42,150 | 0 | 103,945 | 61.8 K to 103.9 K (+68.21 %) |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | 5AM Partners IV, LLC | 10% Owner | Buy | C | 0.00 | 61,795 | 0 | 61,795 | 0 to 61.8 K |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | 5AM Partners IV, LLC | 10% Owner | Buy | P | 14.00 | 628,572 | 8,800,008 | 3,123,302 | 2.5 M to 3.1 M (+25.20 %) |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | 5AM Partners IV, LLC | 10% Owner | Buy | C | 0.00 | 1,011,623 | 0 | 2,494,730 | 1.5 M to 2.5 M (+68.21 %) |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | 5AM Partners IV, LLC | 10% Owner | Buy | C | 0.00 | 1,483,107 | 0 | 1,483,107 | 0 to 1.5 M |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | ORBIMED ADVISORS LLC | 10% Owner | Option Exercise | C | 0.00 | 18,500,000 | 0 | 0 | |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | P | 14.00 | 833,333 | 11,666,662 | 3,409,865 | 2.6 M to 3.4 M (+32.34 %) |
| Nov 21 2017 | SCPH | scPharmaceuticals ... | ORBIMED ADVISORS LLC | 10% Owner | Buy | C | 0.00 | 2,576,532 | 0 | 2,576,532 | 0 to 2.6 M |
Page: 1